Article Information
History
- April 27, 2022.
Article Versions
- You are currently viewing Version 1 of this article (April 27, 2022 - 09:43).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Peter D Smits, PhD1,
- Samuel Gratzl, PhD1,
- Michael Simonov, MD1,2,
- Senthil K Nachimuthu, MD, PhD1,
- Brianna M Goodwin, MS1,
- Michael D Wang, MD1,
- Benjamin M Althouse, PhD, ScM1,3,4 and
- Nicholas L Stucky, MD, PhD1,‡
- 1Truveta Incorporated, Bellevue, WA
- 2Yale School of Medicine, New Haven, CT
- 3Information School, University of Washington, Seattle, WA
- 4Department of Biology, New Mexico State University, Las Cruces, NM
- ↵‡To whom correspondence should be addressed Dr Nicholas L Stucky, Truveta, Inc, 1745 114th Ave SE, Bellevue, WA 98004, Email: nicholass{at}truveta.com
Posted April 27, 2022.
Risk of COVID-19 breakthrough infection and hospitalization in individuals with comorbidities
